Center of Diagnosis and Treatment of Intravenous Immunoglobulin-Refractory Kawasaki Disease

Zhenhong Du
2012-01-01
Abstract:Intravenous immunoglobulin(IVIG)therapy together with aspirin is effective in Kawasaki disease(KD).However,some of KD patients have persistent or recurrent fever after IVIG treatment;further more,these patients are at higher risk of developing coronary artery abnormalities.But pathogenesis of intravenous immunoglobulin refractory KD is still unclear.Many risk factors are associated with intravenous immunoglobulin-refractory KD,such as small age of patients,days of illness at initial treatment ≤4,increase of white blood cell,AST and CRP,high percentage of neutrophil and decrease of plasma albumin and platelet.Treatments of intravenous immunoglobulin-refractory KD patients are still in dispute,but additional IVIG is well accepted.Other treatments are also in further research,such as corticosteroids,infli-ximab and plasma exchange.The domestic and foreign research progress about incidence,pathogenesis,risk factors and treatment of intravenous immunoglobulin-refractory KD are summarized in this article.
What problem does this paper attempt to address?